Chronic subdural hematomas and the elderly: surgical results from a series of 125 cases: Old “horses” are not to be shot! by Silva, Danilo Otávio de Araújo et al.
Surgical Neurology International Editor-in-Chief:James I. Ausman, MD, PhD 
University of California, Los 
Angeles, CA, USA
OPEN ACCESS
For entire Editorial Board visit :  
http://www.surgicalneurologyint.com
Original Article
Chronic subdural hematomas and the elderly: Surgical results 
from a series of 125 cases: Old “horses” are not to be shot!
Danilo Otávio de Araújo Silva, Georgios K. Matis1, Leonardo Ferraz Costa, 
Matheus Augusto Pinto Kitamura, Eduardo Vieira de Carvalho Junior, Monalisa de Moura Silva, 
Breno José A. P. Barbosa, Carlos Umberto Pereira2, Joacil Carlos da Silva, Theodossios A. Birbilis1, 
Hildo Rocha Cirne de Azevedo Filho
Department of Neurosurgery, Hospital da Restauração, Recife, Pernambuco, Brazil, 1Democritus University of Thrace Medical School, Alexandroupolis, Greece, 
2Federal University of Sergipe, Aracaju, Sergipe, Brazil
E‑mail: *Danilo Otávio de Araújo Silva ‑ daniloncr@gmail.com; Georgios K. Matis ‑ gkmatis@yahoo.gr; Leonardo Ferraz Costa ‑ leosport2000@yahoo.com.br; 
Matheus Augusto Pinto Kitamura ‑ matheus_kitamura@hotmail.com; Eduardo Vieira de Carvalho Junior ‑ evcj2005@gmail.com;  
Monalisa de Moura Silva ‑ monalisa@gmail.com; Breno José A. P. Barbosa ‑ brenojb@gmail.com; Carlos Umberto Pereira ‑ umberto@infonet.com.br; J 
oacil Carlos da Silva ‑ jneurosurgery@gmail.com; Theodossios A. Birbilis ‑ mpirmpil@otenet.gr; Hildo Rocha Cirne de Azevedo Filho ‑ azevedoh@uol.com.br 
*Corresponding author
Received: 15 August 12 Accepted: 27 September 12 Published: 14 December 12
Abstract
Background: To present the accumulated experience from treating chronic 
subdural hematomas (CSDH) in a local hospital of a third world country.
Methods: One hundred and twenty‑five consecutive patients with CSDH who were 
surgically treated in the Neurosurgical Department of the Hospital da Restauração, 
Recife‑PE, Brazil, between January 2006 and May 2008, were retrospectively 
studied. Glasgow Outcome Scale (GOS) was employed to define outcome at 
6 months as good (GOS 4 and 5) or poor (GOS ≤ 3). Age, admission Glasgow 
Coma Scale (GCS), location of hematomas (unilateral/bilateral), drainage system 
placement and recurrence were all analyzed for potential impact on final outcome.
Results: The median age was 69 years, with a male/female ratio of 102/23. History 
of trauma was present in 60.8% of the patients. The median GCS on admission was 
14. In 64 patients, the hematoma was on the left side, while in 42 patients it was 
on the right side. Bilateral hematomas were present in 19 cases (15.2%). Drainage 
systems were used in 93.6% of the cases. Recurrence occurred in 8.8% of the 
patients. One hundred and three patients obtained a good outcome at 6 months. 
The mortality rate was 11.2%. Patients with GCS ≥9 on admission presented better 
outcome (P < 0.05). Recurrent cases presented a poor outcome (P < 0.05).
Conclusions: This study suggests that the main factors associated with outcome in 
patients harboring CSDH are the admission GCS score and the recurrence status. 
Advanced age is not a contraindication for surgical treatment. This study, solely 
focused on the Brazilian population, is the first of its kind in the English literature, 
and it could serve as a useful introduction to a more complex, multivariate, debate.
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INTRODUCTION
Chronic subdural hematomas (CSDHs) are defined as 
dark-red liquefied blood collections surrounded by a thin 
capsule, typically requiring about 3 weeks to develop.[20] 
They are commonly associated with old alcohol-addicted 
male patients, with a history of head trauma and 
concomitant coagulopathy.[1,4,10,12,28,32,33,35] The mortality 
rate varies between 8% and 15.6%.[4,7,28] However, specific 
groups of patients, such as those with coagulation 
abnormalities and older people, demonstrate a more 
elevated mortality rate.[4,35] In the past, several authors 
have analyzed the outcome of surgically treated patients 
with CSDH regarding factors such as bilateral localization, 
recurrence, placement or not of drainage systems, 
drainage blood volume, gender, admission Glasgow Coma 
Scale (GCS) and surgical technique, but the results were 
not always consistent.[4,7,10,11,18,19,23,24,28,30,32,35,36]
The authors present herein the outcome at 6 months 
of a series of 125 patients surgically treated for CSDH 
and explore the significance of various demographic, 
clinical and surgical variables. This is the first 
report (in the English literature) addressing this issue 
exclusively in Brazilian patients.
MATERIALS AND METHODS
During the period January 2006 to May 2008, 125 
consecutive patients admitted to the Department of 
Neurosurgery (Hospital da Restauração, Recife-PE, 
Brazil), who received surgical treatment for CSDH, were 
retrospectively reviewed. Approval of the Research Ethic 
Committee of the Hospital was obtained. Data were 
retrieved from the patients’ medical records.
Diagnosis of CSDH was confirmed by computed 
tomography (CT) in all patients. General anesthesia was 
administered during operation. No operation in this series 
was performed with sedation or local anesthesia.
All patients underwent surgical intervention, which 
included burr hole and irrigation of the hematoma with 
saline solution. Most of the patients (n = 117, 93.6%) 
received one or two drainage systems for a time period 
of 3 days. If craniotomy was needed (recurrent cases), the 
capsule was removed as far as possible.
Outcome was evaluated by the Glasgow Outcome 
Scale (GOS) at 6 months, and classified patients in two 
groups; those with poor (GOS 1-3) and those with good 
outcome (GOS 4-5). The variables considered included 
age, admission GCS, unilateral or bilateral localization 
and recurrence. The relation between recurrence and 
drainage system insertion was also analyzed.
Statistical analyses were conducted using commercially 
available software (GraphPad Prism 4.0; GraphPad 
Software Inc: La Jolla, CA, USA). For 2 × 2 tables, the 
Chi-square test and the Fischer exact test (when one or 
more of the expected frequencies was <5) were performed 
for all variables. The level of significance was set at 5%.
RESULTS
Demographics-clinical presentation
The median age of the patients was 
69 years (range: 5-98 years). The patients were divided 
in only two age groups due to their limited number; 
those being younger than 60 years and those older than 
60 years. The male sex was dominant in this series, 
with a male/female ratio of 102/23.
The median value of the GCS at admission was 14 
(range: 4-15). History of trauma was present in 76 
patients (60.8%). Headache was a common symptom, 
occurring in 50 patients (40%), while contralateral 
motor deficit was present in 55 patients (44%). The 
basic features of the patients are provided in Table 1, 
including the underlying risk factors (i.e. anticoagulants, 
antiplatelet drugs, hypertension, etc.). Table 2 presents 
the major findings of similar articles found in the 
literature, none of which concern Brazilian patients.
Operative considerations
The hematoma was on the left side in 
64 patients (51.2%) and on the right side in 
42 patients (33.6%). Bilateral hematomas were present 
in 19 cases (15.2%). Sometimes, septa divided the 
subdural space in multiple compartments. Drainage 
systems were used in 117 patients (93.6%). Recurrence 
occurred in 11 patients (8.8%). There were no cases of 
postoperative meningitis. Wound infection occurred in 
three cases (2.4%).
Outcome
The median GOS at 6 months was 4 (range: 1-5). One 
hundred and three patients obtained a good outcome, 
representing 82.4% of the patients. Mortality rate 
was 11.2% (14 patients). In this series, six patients 
died of pulmonary infection or sepsis, five due to 
cardiovascular diseases and three due to unknown 
causes (recurrent hematomas).
Age was not statistically associated with 
outcome (P > 0.05) [Figure 1]. Bilateral hematomas 
were neither associated with outcome nor 
recurrence (P > 0.05) [Figures 2 and 3]. The placement 
or absence of placement of a drainage system did not 
yield statistically significant results with respect to 
recurrence (P > 0.05) [Figure 4].
Patients presenting with an admission GCS 
score ≥9 had a statistically significant better 
outcome (P = 0.0033) [Figure 5]. As expected, 
patients with recurrent hematomas had poor 
Surgical Neurology International 2012, 3:150 http://www.surgicalneurologyint.com/content/3/1/150
Figure 1: Age groups of patients according to outcome (Glasgow 
Outcome Score)
Figure 2: Location of chronic subdural hematoma and outcome 
(Glasgow Outcome Score)
Figure 3: Recurrence of chronic subdural hematoma and location
outcome (P = 0.0066) [Figure 6]. Postoperative 
hydrocephalus and cerebrospinal fluid leak were 
not found to correlate with outcome in this 
study (P > 0.05).
Figure 4: Use of drainage and recurrence
Figure 5: Admission Glasgow Come Scale and outcome (Glasgow 
Outcome Score)
Figure 6: Recurrence of chronic subdural hematoma and outcome 
(Glasgow Outcome Score)
DISCUSSION
CSDH is a common surgical entity in the neurosurgical 
practice, but it still remains to be clarified which is the 
main factor influencing outcome [Table 2].
Demographics
CSDH is a condition mostly present in older 
people (50-70 years of age).[10,18,23,24] Men are more 
commonly affected than women.[10,24,27,35] Our patients had 
a history of head trauma in 60.8% of the cases, a finding 
consistent with the literature, which reports such a history 
varying between 35% and 75% of patients.[9,11,21,25,27,35] 
Surgical Neurology International 2012, 3:150 http://www.surgicalneurologyint.com/content/3/1/150
Furthermore, coagulation abnormalities represent a very 
important clinical factor associated with the presence, 
natural history and mortality rate of CSDH. A study has 
shown a higher mortality rate in the postoperative period in 
Table 1: Demographic and clinical features in 125 cases 
of CSDH
Features (%)
Sex
Male, nr. 102 (81.6)
Female, nr. 23 (18.4)
Age at presentation, years
≤60, nr. (mean±SD) 38 (30.4) (57±2.9)
>60, nr. (mean±SD) 87 (69.6) (76±4.2)
Risk factors
Hypertension, nr. 28 (22.4)
Diabetes, nr. 13 (10.4)
Neurosurgical procedures, nr. 11 (8.8)
Alcoholism, nr. 10 (8)
Ticlopidine, nr. 5 (4)
Aspirin, nr. 2 (1.6)
Ticlopidine+aspirin, nr. 4 (3.2)
Warfarin, nr. 2 (1.6)
Admission GCS score
≤8 nr. (mean±SD) 15 (12) (6.3±0.5)
>9 nr. (mean±SD) 110 (88) (14.1±1.8)
History of head trauma
Yes, nr. 76 (60.8)
No, nr. 24% (39.2)
Symptoms–signs
Headache, nr. 50 (40)
Motor deficits, nr. 55 (44)
Seizures, nr. 11 (8.8)
Speech disturbance, nr. 57 (45.6)
Gait disturbance, nr. 76 (60.8)
Localization of CSDH
Left, nr. 64 (51.2)
Right, nr. 42 (33.6)
Bilaterally, nr. 19 (15.2)
Drainage system
Yes, nr. 117 (93.6)
No, nr. 8 (6.4)
Recurrence
Yes, nr. 11 (8.8)
No, nr. 114 (91.2)
GOS
<3, nr. 12 (17.6)
≥4, nr. 103 (82.4)
Etiology of death
Infection–sepsis, nr. 6 (4.8)
Cardiovascular diseases, nr. 5 (4)
Other, nr. 3 (2.4)
CSDH: Chronic subdural hematomas, GCS: Glasgow coma scale, GOS: Glasgow 
outcome scale, SD: Standard deviation, Nr: Number
patients with international normalized ratio (INR) greater 
than 1.25 and/or thrombocytopenia.[35] Our data failed to 
assess this association because not all of our patients had 
available preoperative coagulation studies.
Surgical technique
In concern to the surgical technique, it is not clear which 
is the best surgical procedure for each patient. Some 
authors advocate twist drill craniostomy, others recommend 
burr hole surgery or even craniotomy. Most of them use 
drainage systems. Carmel et al. reported on a large series 
of patients operated by twist-drill craniostomy, where 86% 
of the patients achieved an excellent outcome.[7] However, 
the majority of the published literature agrees that optimal 
surgical treatment is achieved with the burr-hole trepanation 
surgery with a closed drainage system.[10,17,20,23,32,36] The 
outcome results based on those series are favorable in 
around 80% of the patients, similar to the results from the 
twist-drill craniostomy series.
Craniotomy still remains the principal treatment for some 
authors. Sambasivan in a very large series of 2300 cases of 
CSDH favors a small temporal craniotomy, with the dura 
left open and the subdural space communicating with the 
subtemporalis area.[28] Hamilton et al. compared 49 cases 
who underwent craniotomy and 43 who underwent 
burr-hole surgery, and found no significant differences 
between the two groups in relation to good outcome, 
postoperative complications, recurrence or mortality.[15]
Our data did not compare different surgical techniques 
because it is our protocol to routinely perform the 
burr-hole surgery as the first treatment modality. We retain 
the craniotomy option only for recurrent cases. The good 
outcome in 82.4% of our patients is comparable with other 
reports.
Recurrence
Recurrence has always been a source of frustration for 
neurosurgeons. Thus, it comes as no surprise that the 
vast majority of the published articles focus on this 
matter. According to the literature, the age of the patient, 
the history of seizure or diabetes mellitus, the bilateral 
localization, the architecture or width of the hematoma 
and the absence of placement of a drainage system are 
among the main reasons for failure.[2,4,20]
Most of the studies discouraging the use of a drainage system 
come from the beginning of the 1980s. Markwalder et al. 
reported a small series of 21 patients with CSDH in whom 
no drainage system was placed, and found no difference in 
the recurrence rate as compared with cases where closed 
drainage systems had been installed.[19] Robinson, in a large 
series of 133 cases treated with burr-hole surgery without 
drainage system, suggested that high-risks patients for 
recurrence are the elderly ones with bilateral hematomas 
and most patients in critical condition.[27] However, these 
studies are not comparative.
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Table 2 : Indicative international studies on CSDH
Reference, 
year, 
country
Nr of 
patients 
(male/
female)
Age (years) Coma on 
admission 
(%)
Head 
trauma 
(%)
Risk factors (%) Localization (%) Outcome Recur-
rence 
rates (%)
Death 
rates 
(%)
[16], 2011, 
Iran
40 (2.3/1) 67±18 7.5 62.5 Diabetes: 10-20
Hypertension: 20
Seizures: 0-5
Antiplatelet/Anticoagulant: 
20-25
NS GOS 5 (6 
months): 60% 
with drainage 
50% without 
drainage
5 with 
drainage 
0 without 
drainage
0.73 with 
drainage
[31], 2010, 
Taiwan
129 
(1/0.29)
71±14 NS 70 Diabetes: 19
Hypertension: 44
Antiplatelet/Anticoagulant: 9
Alcoholism: 4
34.9 unilateral
65.1 bilateral
After surgery: 
91% improved
9 8
[13], 2004, 
Italy
159 
(1.7/1)
76.4 (29-96) 4 64 Diabetes: 11
Hypertension: 36
Antiplatelet/Anticoagulant: 12
Alcoholism: 2
30 bilateral Markwalder 
grade (at 
discharge):  
0: 84%
1: 12%
6.3 3
[22], 2001, 
Japan
500 
(0.7/0.3)
67.3±15.3 
(males) 
71.3±14.2 
(females)
2.4 57 Diabetes: 8
Hypertension: 18.6
Antiplatelet/Anticoagulant: 5.2
Alcoholism: 6
Cerebral infarction: 4.2
Neurosurgical operations: 8
Coagulopathy: 3
Arachnoid cyst: 2
52 left 
30.4 right
17.6 bilateral
1 month post-
operatively:
89.4% better
8.4% no change
2.2% worse
9.8 1.2
[28], 1997, 
India
2,300 
(5/1)
<60: 72.1%
>60: 27.9%
14.9 76 Antiplatelet/Anticoagulant: 6
Alcoholism: 14
74.4 unilateral
25.5 bilateral
0.4 
interhemispheric
GOS 4‑5 (18 
months): 84%
0.35‑21.5 0.5‑4
Nr: number, NS: Not stated
Wakai et al. conducted a prospective comparative 
study with 38 patients on the recurrence rate of CSDH 
after surgery with (group A) and without (group B) 
closed system drainage.[32] There were no significant 
differences between the two groups for sex, age, 
preoperative hematoma volume and density on CT 
scan. Recurrence rate in group A was 5% (one case) as 
opposed to 33% in group B (six cases) (P < 0.05). The 
authors conclude that closed system drainage reduces 
the recurrence rate of CSDH.
Yamamoto et al. analyzed independent predictors 
of recurrence of CSDH and found four variables 
associated with recurrence: presence of hematoma 
cavities on CT scans, history of seizure, width of the 
hematoma and history of diabetes mellitus.[34] Another 
report by Nakaguchi et al. emphasizes that the internal 
architecture of the hematoma is an important factor 
and that the recurrence rate is higher for separated types 
and cranial base hematomas.[24] Bilateral hematomas 
are also associated with a high risk of recurrence in the 
published literature.[20,29,30]
The direction of the drainage catheter during its 
placement has been also studied by some authors. 
Nakaguchi et al. believe that the incidence of 
postoperative fluid reaccumulation is reduced by 
placing the tip of the drainage catheter in the subdural 
frontal convexity and by removing subdural air during or 
after surgery.[23] Nevertheless, positioning the tip of the 
catheter in contact with the hematoma capsule in the 
subdural space may increase the risk of postoperative 
seizures and secondary intracranial infections.[36]
There seems to be a controversy regarding the postoperative 
drainage volume of CSDH. Kwon et al., reporting on 
a series of 175 patients with CSDH, stated that less 
postoperative drainage volume than expected is associated 
with a high possibility of recurrence.[18] The opposite is 
supported by Matsumoto et al., who published a series of 
121 cases and concluded that the drainage volume was 
significantly larger in recurrent cases than in nonrecurrent 
cases.[20] The recurrence rate increased in proportion to the 
drainage volume. Other factors associated with recurrence 
were hematoma thickness and diabetes mellitus.[20]
Abouzari et al. analyzed another important factor for 
recurrence of CSDH, the role of postoperative patient 
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posture.[1] Their conclusion was that assuming an upright 
posture soon after burr-hole surgery was associated with 
a significantly increased incidence of recurrence but 
not with a significant change in other position-related 
postsurgical complications.
Our recurrence rate was 8.8% in this series, a percentage 
similar to the ones previously published. Neither 
bilateral localization (P > 0.05) nor the use of drainage 
system (P > 0.05) was associated with recurrence 
according to these data. A drainage system was placed in 
almost 94% of our cases as a standard protocol procedure; 
therefore, the result might be biased. Thus, comparison 
between the recurrence rate in those who harbored a 
drainage system and those who did not cannot draw any 
statistically significant conclusions. From the 11 patients 
with recurrent hematomas, seven (63.6%) were ≥60 years 
old and four (36.4%) were <60 years old (P > 0.05).
Outcome
Historically, it has been known that older age, bilateral 
CSDH, low admission GCS score and recurrent 
hematomas are related to worse outcomes and increased 
mortality in patients undergoing surgical treatment 
for CSDH. Antunes et al. reported on a series of a 
100 patients >75 years of age with a mortality rate 
of 15.6%.[4] This percentage is much higher than the 
mortality rates presented in other series, which did not 
address specifically the elderly population: 0.5%,[28] 
1.5%,[27] 3.4%,[36] 4.4%[15] and 8%.[7] Yet, the author 
concluded that more than 60% of the patients were 
completely cured and that advanced age should not be 
considered a contraindication to surgery.[4] However, 
recurrence of CSDH was not associated with poor 
outcome and higher mortality rates in the publications 
of Ramachandran et al. and Gelabert-González et al.[26,14] 
Our study found that recurrence is associated with poor 
outcome at 6 months of follow-up (P = 0.0066).
Tsai et al. conducted a retrospective study comparing the 
outcome of bilateral and unilateral CSDH, and found 
that although the symptoms of increased intracranial 
pressure were more prominent in patients with bilateral 
hematomas, the postoperative outcome was similar to 
both groups.[31] In agreement with this article, our data 
did not show a statistically significant association between 
age or bilateral localization with outcome at 6 months.
Another significant factor determining outcome is 
the GCS score on admission.[2,3]Amirjamshidi et al. 
demonstrated in consecutive publications that lower 
admission GCS scores result in worse outcome, as 
this is measured by GOS, and higher mortality.[2,3] 
These results are in line with our data, suggesting that 
patients with an admission GCS score ≥9 present good 
outcome (P = 0.0033).
Limitations of the study
This study has some limitations. The major limitation 
is its retrospective nature. Yet, the authors’ standardized 
surgical approach and the consistent outcome evaluation 
at 6 months as a routine practice greatly facilitated the 
objective collection of data. Stratification by age in only 
two groups due to the limited number of patients could 
also raise some “oversimplification” issues. Of note, due 
to technical issues, the laboratory coagulations tests could 
not be retrieved. Thus, the role of abnormal coagulation 
status on final outcome could not be assessed. This 
series did not also analyze the relation between history 
of seizures or diabetes mellitus, width and architecture 
of the hematoma and postoperative drainage volume 
with recurrence. The authors have initiated a prospective 
study to face these issues, validate further and extend the 
findings of the current retrospective analysis.
CONCLUSION
Our data suggest that an admission GCS score ≥9 is 
associated with good outcome in patients who undergo 
surgical treatment for CSDH at 6 months postoperatively. 
On the contrary, recurrence is associated with poor outcome 
at the same period. Interestingly, our findings support the 
thesis that age is not associated with outcome in patients 
with CSDH. Thus, elderly patients could actually benefit 
from a surgical treatment, and they should be provided 
with that option. Finally, the presence of bilateral CSDH 
seems to have no relation with outcome or recurrence in 
these patients. This study could serve as an introduction to 
a more complex, multivariate debate specifically focused on 
the Brazilian population.
The authors report no conflict of interest related to this 
article.
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